Cardinal Health, Inc.
CAHNYSEHealthcare● Active
$205.71
+$3.97(+1.97%)
Market Cap$48.2B
P/E Ratio—
52W High$233.6
52W Low$137.75
Cardinal Health, Inc. (CAH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CAH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$3.17
Est. $2.79 · +13.6%
Revenue
$60.94B
Est. $62.10B · -1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 11-Quarter EPS Beat Streak
CAH reports quarterly as a NYSE-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | $2.41 | — | — | — | $65.22B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $2.79 | $3.17 | +13.6% | $60.94B | $62.10B | -1.9% |
| ▲ Q1 FY2026 | Feb 5, 2026 | $2.34 | $2.63 | +12.4% | $65.63B | $65.08B | +0.8% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $2.18 | $2.55 | +17.0% | $64.01B | $59.24B | +8.1% |
| ▲ Q3 FY2025 | Aug 12, 2025 | $2.04 | $2.08 | +2.0% | $60.16B | $60.89B | -1.2% |
| ▲ Q2 FY2025 | May 1, 2025 | $2.17 | $2.35 | +8.3% | $54.88B | $55.39B | -0.9% |
| ▲ Q1 FY2025 | Jan 30, 2025 | $1.74 | $1.93 | +10.9% | $55.26B | $55.02B | +0.5% |
| ▲ Q4 FY2024 | Nov 1, 2024 | $1.62 | $1.88 | +16.1% | $52.28B | $50.90B | +2.7% |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
$2.41
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$3.17
EPS Est.
$2.79
EPS Surpr.
+13.6%
Revenue
$60.94B
Q1 FY2026
Feb 5, 2026Beat
EPS Actual
$2.63
EPS Est.
$2.34
EPS Surpr.
+12.4%
Revenue
$65.63B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$2.55
EPS Est.
$2.18
EPS Surpr.
+17.0%
Revenue
$64.01B
Q3 FY2025
Aug 12, 2025Beat
EPS Actual
$2.08
EPS Est.
$2.04
EPS Surpr.
+2.0%
Revenue
$60.16B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$2.35
EPS Est.
$2.17
EPS Surpr.
+8.3%
Revenue
$54.88B
Q1 FY2025
Jan 30, 2025Beat
EPS Actual
$1.93
EPS Est.
$1.74
EPS Surpr.
+10.9%
Revenue
$55.26B
Q4 FY2024
Nov 1, 2024Beat
EPS Actual
$1.88
EPS Est.
$1.62
EPS Surpr.
+16.1%
Revenue
$52.28B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2030 | $4.16 | $4.27 | $4.36 | 2 |
| Q1 FY2030 | $4.80 | $4.92 | $5.03 | 2 |
| Q4 FY2029 | $4.32 | $4.43 | $4.53 | 4 |
| Q3 FY2029 | $4.20 | $4.31 | $4.40 | 3 |
| Q2 FY2029 | $3.66 | $3.75 | $3.83 | 3 |
| Q1 FY2029 | $4.24 | $4.35 | $4.44 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2030 | $83.0B | $84.7B | $86.1B | 2 |
| Q1 FY2030 | $80.7B | $82.3B | $83.7B | 3 |
| Q4 FY2029 | $85.0B | $86.7B | $88.1B | 3 |
| Q3 FY2029 | $83.7B | $85.4B | $86.8B | 2 |
| Q2 FY2029 | $77.1B | $78.7B | $80.0B | 2 |
| Q1 FY2029 | $75.3B | $76.8B | $78.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +13.6% | $202.82 | $192.88 | -4.90% |
| ▲ Q1 FY2026 | Feb 5, 2026 | +12.4% | $206.85 | $227.18 | +9.83% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +17.0% | $164.47 | $189.84 | +15.43% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +2.0% | $157.66 | $146.30 | -7.21% |
| ▲ Q2 FY2025 | May 1, 2025 | +8.3% | $141.29 | $145.53 | +3.00% |
| ▲ Q1 FY2025 | Jan 30, 2025 | +10.9% | $127.76 | $128.26 | +0.39% |
| ▲ Q4 FY2024 | Nov 1, 2024 | +16.1% | $108.52 | $116.13 | +7.01% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +6.4% | $102.58 | $106.36 | +3.68% |
Q2 FY2026-4.90%
Report Date
Apr 30, 2026
EPS Beat/Miss
+13.6%
Price Before
$202.82
Price After
$192.88
Q1 FY2026+9.83%
Report Date
Feb 5, 2026
EPS Beat/Miss
+12.4%
Price Before
$206.85
Price After
$227.18
Q4 FY2025+15.43%
Report Date
Oct 30, 2025
EPS Beat/Miss
+17.0%
Price Before
$164.47
Price After
$189.84
Q3 FY2025-7.21%
Report Date
Aug 12, 2025
EPS Beat/Miss
+2.0%
Price Before
$157.66
Price After
$146.30
Q2 FY2025+3.00%
Report Date
May 1, 2025
EPS Beat/Miss
+8.3%
Price Before
$141.29
Price After
$145.53
Q1 FY2025+0.39%
Report Date
Jan 30, 2025
EPS Beat/Miss
+10.9%
Price Before
$127.76
Price After
$128.26
Q4 FY2024+7.01%
Report Date
Nov 1, 2024
EPS Beat/Miss
+16.1%
Price Before
$108.52
Price After
$116.13
Q3 FY2024+3.68%
Report Date
Aug 14, 2024
EPS Beat/Miss
+6.4%
Price Before
$102.58
Price After
$106.36
Avg Beat Reaction+3.40%
Beat Rate8 / 8 quarters
Largest Move+15.43% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CAH ends December
Cardinal Health, Inc. (CAH) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $3.17 — beating the analyst consensus of $2.79 by +13.6%. CAH has beaten EPS estimates for 11 consecutive quarters. The next CAH earnings date is expected around September 1, 2026.
Each quarter, investors track CAH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CAH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CAH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CAH earnings · 5 questionsCardinal Health, Inc.'s next earnings report is expected around September 1, 2026. CAH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CAH historically reports after market close (AMC).
CAH earnings datewhen is CAH earningsCAH next earnings datewhen does CAH report earningsCAH earnings calendar
▸ Source: FMP · Cardinal Health, Inc. SEC filings · US GAAP · Cardinal Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026